MarTech Minute: Folloze’s new ABM solution, Lifesize takes over CCaaS platform

Our MarTech Minute briefs first appear in the MarTech Today daily newsletter. Click here to subscribe so that you can start your day “in the know” for all things martech-related.

ABM GETS PERSONAL: Folloze has launched a Personalized Marketing Platform for ABM programs that uses machine learning technology to deliver personalized experiences throughout the customer lifecycle. Why we care: Here’s that word again: personalization. Get used to it, because it is as buzzy as it gets right now. What’s interesting here is B2B marketers are also finding that their customers expect the same personalization tactics used in B2C marketing campaigns, so having access to a platform that can provide personalized experiences across ABM touchpoints helps. Source: Folloze

VIDEO MAKES THE (CX) WORLD GO ROUND. It looks like video collaboration and meeting solution provider Lifesize has taken over Serenova, a contact-center-as-a-service (CCaaS) platform with the financial backing of from Marlin Equity Partners (they are calling it a merger). Lifesize CEO Craig Mallory will serve as CEO of the new company and Serenova’s CEO John Lynch will take on the role of senior VP of sales. Why we care: Video collaboration is certainly getting a lot of attention now as coronavirus forces more virtual work, but it’s worth noting that these tools are increasingly more important for us as marketing organizations take over more of the customer journey and customer service initiatives. Source: Serenova

The post MarTech Minute: Folloze’s new ABM solution, Lifesize takes over CCaaS platform appeared first on Marketing Land.



Top rated Digital marketing. From $30 Business growth strategy Hello! I am Sam, a Facebook blueprint certified marketer. Expert in Facebook Ads, Instagram Ads, Google Ads, YouTube Ads, and SEO. I use SEMrush and other tools for data-driven research. I can build million-dollar marketing strategy for your business.
Learn more
Reactions

Post a Comment

0 Comments